• Skip to primary navigation
  • Skip to main content
DB-I Logo

DenseBreast-info, Inc.

Get Smart About Being Dense

HOME/USA

EUROPE

Español

  • Home
  • For Patients
    • Patients Home
    • Dense Breasts: 5 Facts You Should Know
    • Is My Mammogram Enough?
    • Screening Tests After a Mammogram (Table)
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Questions and Answers
    • Patient Resources by Language
    • Print: Patient Fact Sheet
    • Print: Patient Brochure
  • For Providers
    • Providers Home
    • CME/CE: “Dense Breasts, Risk, and Supplemental Screening”
    • Flow Chart: Who Needs More Screening?
    • Health Care Provider FAQs
    • Risk Model Tutorial
    • Table: Mammography Guideline Comparison
    • Table: Dense Breast Screening Guidelines
    • Table: High/Increased-Risk Screening Guidelines
    • DBI Research
    • Patient Resources
  • Screening Technologies
    • Screening Technologies Home
    • For Patients: Screening Tests After a Mammogram (Table)
    • For Providers: Cancer Detection by Screening Method (Table)
    • 2D/3D Mammography
    • Mammography AI Screening Tools, Comparative Tables
    • Breast Ultrasound (Sonogram)
    • Breast MRI
    • Contrast-Enhanced Mammography (CEM)
    • Molecular Breast Imaging
    • DBI Research
  • Inform/Insurance Laws
    • Inform/Insurance Laws Home
    • Inform: Federal FDA Dense Breast Reporting
    • Insurance
      • State Law Insurance Map and Federal HRSA Guidelines
      • State Law Insurance Table
      • Federal Insurance Bill: Find It Early Act
  • Blog & Press
  • About Us
    • About Us Home
    • Our Mission
    • World Dense Breast Day
    • Our Team
    • DBI Research
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Resources
    • Contact Us
    • Please Donate
  • Our Corporate and Health Group Supporters
/ Blog / USPSTF, ACR Recommendations, U.S. Insurance Legislation
USPSTF, ACR Recommendations, U.S. Insurance Legislation | Dense Breast Info

USPSTF, ACR Recommendations, U.S. Insurance Legislation

May 15, 2023 by Dense Breast Info

United States Preventive Services Task Force (USPSTF)
USPSTF updated screening guidelines updates were just published and now include the recommendation that mammography screening in normal risk women occur every other year beginning at 40 (was 50).  Unfortunately, for women with dense breasts, the recommendations incorrectly conclude there is “inadequate” evidence to support adding supplemental screening ultrasound or MRI after a mammogram and fail to recognize the important of annual screening.

  • See DBI’s Public Position, “The USPSTF Guideline Should Not Apply to Women with Dense Breasts.”
  • NEXT WEEK: look for JBI Opinion piece, “USPSTF Guideline Fails to Address Dense Breasts,” which includes a literature review. We will also share DBI comments to the USPSTF.

2023 ACR Screening Recommendations for Women at Higher Risk
New recommendations just published! For women at higher-than-average risk of breast cancer, the ACR recommends annual digital mammography, beginning between ages 25 and 40, and supplemental screening, depending on risk, with breast MRI as the supplemental method of choice. Notably, women with extremely dense breasts are considered to have approximately twice the “average” risk, and for women with dense breasts who desire supplemental screening, breast MRI is recommended.

Federal Bill, the Find It Early Act
The federal insurance bill, the Find It Early Act, has been re-introduced in this session of Congress by Reps. DeLauro and Fitzpatrick. Their announcement HERE.

New U.S. State Insurance Laws
Insurance coverage for breast imaging has been signed into law in:

  • Pennsylvania (Act 1 of 2023). The law provides for “all costs associated with one supplemental breast screening every year if a woman is believed to be at an increased risk of breast cancer” due to specified reasons. The law also provides coverage for BRCA-related genetic counseling and genetic testing.
  • Maryland (Chapter 0298). The law prohibits, “… except under certain circumstances, insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for diagnostic and supplemental breast examinations from imposing a copayment, coinsurance, or deductible requirement for the examination.”

For more details, please visit the DBI Legislative Information tab.

DenseBreast‑info, Inc. is an independent, nonprofit organization. DBI is not affiliated with or endorsed by other organizations unless expressly identified. If you have questions about DBI’s programs or partnerships, please contact us.

© Unpublished, DenseBreast-info, Inc. ALL RIGHTS RESERVED | 501(c)(3) Public Charity

  • Online Privacy Policy
  • Online Terms of Use & Disclaimers

This website is for informational purposes only and is not intended to be a substitute for medical advice from a physician or to create a standard of care for health care providers. In addition, information has been provided by independent third parties and may not represent the views of DenseBreast-info.org. Please check with a physician regarding your specific condition, if you have any questions, or need a diagnosis. If you are experiencing an urgent medical condition, call your local emergency services [e.g., 9-1-1 (in the USA) or 1-1-2 (in Europe)].